Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.

MLA

Li, Ying-Hong, et al. “Design, Synthesis, and Cholesterol-Lowering Efficacy for Prodrugs of Berberrubine.” Bioorganic & Medicinal Chemistry, vol. 18, no. 17, Sept. 2010, pp. 6422–28. EBSCOhost, https://doi.org/10.1016/j.bmc.2010.06.106.

APA

Li, Y.-H., Li, Y., Yang, P., Kong, W.-J., You, X.-F., Ren, G., Deng, H.-B., Wang, Y.-M., Wang, Y.-X., Jiang, J.-D., & Song, D.-Q. (2010). Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorganic & Medicinal Chemistry, 18(17), 6422–6428. https://doi.org/10.1016/j.bmc.2010.06.106

Chicago

Li, Ying-Hong, Yi Li, Peng Yang, Wei-Jia Kong, Xue-Fu You, Gang Ren, Hong-Bin Deng, et al. 2010. “Design, Synthesis, and Cholesterol-Lowering Efficacy for Prodrugs of Berberrubine.” Bioorganic & Medicinal Chemistry 18 (17): 6422–28. doi:10.1016/j.bmc.2010.06.106.